Jaleh Varshosaz Selected Research

Imides

11/2019	Tissue Distribution and Systemic Toxicity Evaluation of Raloxifene Targeted Polymeric Micelles of Poly (Styrene-Maleic Acid)-Poly (Amide- Ether-Ester-Imide)-Poly (Ethylene Glycol) Loaded With Docetaxel in Breast Cancer Bearing Mice.
7/2018	Synthesis, in vitro characterization, and anti-tumor effects of novel polystyrene-poly(amide-ether-ester-imide) co-polymeric micelles for delivery of docetaxel in breast cancer in Balb/C mice.
1/2018	Antitumor activity of raloxifene-targeted poly(styrene maleic acid)-poly (amide-ether-ester-imide) co-polymeric nanomicelles loaded with docetaxel in breast cancer-bearing mice.
1/2018	Synthesis and In vitro/In vivo Characterization of Raloxifene Grafted Poly(Styrene Maleic Acid)-Poly(Amide-Ether-Ester-Imide) Micelles for Targeted Delivery of Docetaxel in G Protein-Coupled Estrogen Receptor Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jaleh Varshosaz Research Topics

Disease

30	Neoplasms (Cancer) 08/2022 - 05/2012
15	Breast Neoplasms (Breast Cancer) 12/2022 - 08/2016
12	Wounds and Injuries (Trauma) 09/2022 - 01/2011
9	Ulcerative Colitis 01/2015 - 01/2009
8	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 09/2012
8	Colitis 01/2015 - 01/2010
6	Inflammation (Inflammations) 08/2022 - 10/2010
6	Melanoma (Melanoma, Malignant) 01/2019 - 01/2014
4	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 01/2014
3	Infections 01/2020 - 12/2010
3	Weight Gain 01/2012 - 01/2009
2	Colonic Neoplasms (Colon Cancer) 04/2022 - 08/2012
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 12/2019
2	Ulcer 06/2021 - 01/2010
2	Hypersensitivity (Allergy) 12/2020 - 12/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 08/2014
2	Lung Neoplasms (Lung Cancer) 08/2020 - 11/2015
2	Prostatic Neoplasms (Prostate Cancer) 07/2020 - 01/2020
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 02/2018
2	Necrosis 01/2020 - 01/2019
2	Vomiting 01/2018 - 01/2014
2	Colorectal Neoplasms (Colorectal Cancer) 01/2014 - 08/2012
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2012 - 01/2009

Drug/Important Bio-Agent (IBA)

34	Pharmaceutical PreparationsIBA 10/2021 - 04/2002
18	MicellesIBA 08/2022 - 05/2012
14	Docetaxel (Taxotere)FDA Link 11/2019 - 01/2015
8	LipidsIBA 03/2021 - 08/2012
8	Dextrans (Dextran)FDA Link 01/2014 - 01/2009
8	Budesonide (Pulmicort)FDA LinkGeneric 01/2012 - 01/2009
7	ChitosanIBA 09/2022 - 12/2016
6	PolymersIBA 12/2019 - 04/2002
6	Acetic Acid (Vinegar)FDA LinkGeneric 01/2015 - 01/2010
5	Folic Acid (Vitamin M)FDA LinkGeneric 01/2020 - 01/2014
4	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 09/2022 - 08/2017
4	ImidesIBA 11/2019 - 01/2018
4	EstersIBA 11/2019 - 01/2018
4	AmidesIBA 11/2019 - 01/2018
4	maleic acid (maleate)IBA 11/2019 - 08/2016
4	Ether (Diethyl Ether)IBA 11/2019 - 01/2018
4	Cytotoxins (Cytolysins)IBA 06/2018 - 08/2012
4	SuspensionsIBA 02/2011 - 01/2010
3	Methotrexate (Mexate)FDA LinkGeneric 12/2022 - 01/2021
3	Saline SolutionIBA 08/2022 - 01/2015
3	Silicon Dioxide (Silica)FDA LinkGeneric 08/2022 - 01/2011
3	HydrogelsIBA 01/2022 - 05/2012
3	Imatinib Mesylate (Gleevec)FDA Link 03/2021 - 01/2019
3	Tyrosine Kinase InhibitorsIBA 08/2020 - 01/2019
3	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 08/2012
3	Styrene (Styrol)IBA 11/2019 - 01/2018
3	Raloxifene Hydrochloride (Evista)FDA Link 11/2019 - 01/2018
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2019 - 08/2016
3	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2017 - 08/2016
3	CholesterolIBA 01/2016 - 08/2012
2	Small Interfering RNA (siRNA)IBA 12/2022 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 12/2022 - 03/2022
2	AcidsIBA 08/2022 - 01/2022
2	gellan gumIBA 08/2022 - 03/2022
2	Glutathione (Reduced Glutathione)IBA 08/2022 - 03/2022
2	Glucosamine (Dona)IBA 08/2022 - 08/2020
2	TabletsIBA 04/2022 - 02/2011
2	SolutionsIBA 04/2022 - 10/2010
2	Sunitinib (Sutent)FDA Link 01/2022 - 12/2019
2	Alanine (L-Alanine)FDA Link 10/2021 - 10/2021
2	BoronIBA 10/2021 - 10/2021
2	methylallyl trisulfide (MATS)IBA 10/2021 - 01/2011
2	Doxycycline (Periostat)FDA LinkGeneric 06/2021 - 03/2020
2	Matrix Metalloproteinase InhibitorsIBA 06/2021 - 03/2020
2	Rituximab (Mabthera)FDA Link 03/2021 - 01/2020
2	SolventsIBA 01/2021 - 01/2015
2	Retinaldehyde (Retinal)IBA 12/2020 - 12/2019
2	Dosage Forms (Dosage Form)IBA 08/2020 - 07/2016
2	Antineoplastic Agents (Antineoplastics)IBA 08/2020 - 01/2018
2	Flutamide (Eulexin)FDA LinkGeneric 07/2020 - 01/2020
2	polyacrylamideIBA 07/2020 - 01/2020
2	punicic acidIBA 07/2020 - 01/2020
2	GelatinIBA 03/2020 - 01/2017
2	poly(butylene adipate-co-butylene terephthalate)IBA 03/2020 - 06/2018
2	Hematoxylin (Haematoxylon)IBA 01/2020 - 11/2019
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2020 - 11/2019
2	Biological ProductsIBA 01/2020 - 06/2018
2	Sorafenib (BAY 43-9006)FDA Link 12/2019 - 10/2019
2	Ethylene Glycol (Monoethylene Glycol)IBA 11/2019 - 01/2018
2	Estrogen ReceptorsIBA 11/2019 - 01/2018
2	GTP-Binding Proteins (G-Protein)IBA 11/2019 - 01/2018
2	PectinsIBA 10/2019 - 01/2012
2	Epirubicin (Ellence)FDA LinkGeneric 02/2018 - 04/2017
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2017 - 08/2012
2	Succinic Acid (Succinate)IBA 04/2017 - 10/2010
2	LigandsIBA 11/2015 - 03/2015
2	Etoposide (VP 16)FDA LinkGeneric 01/2014 - 01/2014
2	EnzymesIBA 07/2013 - 05/2012
2	Trinitrobenzenesulfonic AcidIBA 11/2012 - 01/2012
2	GlucocorticoidsIBA 01/2012 - 01/2009
2	methylmethacrylate-methacrylic acid copolymerIBA 01/2012 - 01/2009
2	ProdrugsIBA 10/2010 - 01/2009
2	Mesalamine (Mesalazine)FDA LinkGeneric 10/2010 - 01/2010
2	Metronidazole (Metric)FDA LinkGeneric 06/2010 - 04/2002

Therapy/Procedure

8	Therapeutics 08/2020 - 01/2014
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2014
2	Injections 01/2020 - 01/2014